qa:qa_dcx-login
Four Core Actions to Fight Infections & Antimicrobial Resistance (AMR)
1
Preventing the Spread
2
Tracking Resistant Bacteria
3
Improving Antibiotic Prescribing and Stewardship
4
Developing Advanced Diagnostics & New Antibiotics
1. Hall, AJ., et al. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis. 2012. https://www.ncbi.nlm.nih.gov/pubmed/22491338
2. CDC Media Relations. Nearly half a million Americans suffer from C. difficile infections in single year. CDC Newsroom. 2015. https://www.cdc.gov/media/releases/2015/p0225-clostridium-difficile.html
3. ModernMedicine Network. Chronic Myeloid Leukemia. Accessed Nov 27 2018. http://www.cancernetwork.com/chronic-myeloid-leukemia/chronic-myeloid-leukemia
4. Woessner, David W et al. Development of an effective therapy for chronic myelogenous leukemia. Cancer J. 2011;17(6):477-86.https://www.ncbi.nlm.nih.gov/pubmed/22157291 5.Goldberg S et al. Considerations for Successful Treatment-free Remission in Chronic Myeloid Leukemia. Clin Lymph, Myel & Leuk. 2017; 18(2):98-10
5. https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(17)30991-6/fulltext